Skip to main content

Table 1 Clinicopathological variables as predictors for disease-specific survival in 249 non-GIST STSs (univariate analyses, log-rank test).

From: The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas

Characteristic

Patients

(n)

Patients

(%)

Median survival

(months)

5-Year survival

(%)

P

Age

     

≤ 60 years

133

53

59

50

0.065

> 60 years

116

47

30

40

 

Gender

     

Male

110

44

41

46

0.390

Female

139

56

45

45

 

Patient nationality

     

Norwegian

167

67

63

51

0.011

Russian

82

33

22

34

 

Histological entity

     

Pleomorphic sarcoma

68

27

29

40

0.102

Leiomyosarcoma

67

27

45

46

 

Liposarcoma

34

14

NR

67

 

MF/MFT

20

8

43

50

 

Angiosarcoma

13

5

10

31

 

Rhabdomyosarcoma

16

6

17

38

 

MPNST

11

5

49

45

 

Synovial sarcoma

16

6

31

29

 

Other STSs

4

2

NR

18

 

Tumor localization

     

Extremities

89

36

100

53

0.348

Trunk

47

29

32

44

 

Retroperitoneum

37

25

25

38

 

Head/Neck

18

7

15

41

 

Visceral

58

23

30

42

 

Tumor size

     

≤ 5 cm

74

30

127

57

0.027

5-10 cm

91

37

44

45

 

> 10 cm

81

32

28

36

 

Missing

3

1

   

Malignancy grade

     

1

61

25

NR

74

<0.001

2

98

39

41

45

 

3

90

36

16

26

 

Tumor depth

     

Superficial

17

7

NR

93

<0.001

Deep

232

93

36

42

 

Metastasis at the time of diagnosis

    

No

206

83

76

53

<0.001

Yes

43

17

10

10

 

Surgery

     

Yes

228

92

59

50

<0.001

No

21

8

5

0

 

Resection margins

     

Free

178

71

127

66

<0.001

Not free/no surgery

71

29

10

18

 

Chemotherapy

     

No

191

77

52

47

0.424

Yes

58

23

29

40

 

Radiotherapy

     

No

176

71

48

46

0.590

Yes

73

29

38

43

 
  1. Abbreviations: non-GIST STS, non-gastro intestinal stromal tumor soft-tissue sarcoma; NR, not reached; MF/MFT, malignant fibroblastic/myofibroblastic tumors; MPNST, malignant peripheral nerve sheath tumor